Independent Data Monitoring Committee recommended continuing Phase IIb study More: Destiny Pharma’s novel antibiotic asset clears safety review Source: News
read moreCompanies will focus on HER2-positive gastric cancer More: Eli Lilly, Pieris collaborate on HER2-positive cancer clinical programme Source: News
read moreDrug cleared for use in SMA patients aged two months or older More: Roche’s SMA treatment Evrysdi bags US approval Source: News
read moreTeva’s Ajovy, chasing Amgen and Lilly drugs, gains steam after autoinjector rollout esagonowsky Mon, 08/10/2020 – 11:12 More: Teva's Ajovy, chasing Amgen and Lilly drugs, gains steam after autoinjector rollout Source: fierce
read moreSun Pharma, Lupin launch U.S. recalls of blood pressure, epilepsy meds fkansteiner Mon, 08/10/2020 – 10:07 More: Sun Pharma, Lupin launch U.S. recalls of blood pressure, epilepsy meds Source: fierce
read moreFiercePharmaPolitics—After drug pricing tensions, industry pushes back at Trump’s ‘Buy American’ order esagonowsky Mon, 08/10/2020 – 09:42 More: FiercePharmaPolitics—After drug pricing tensions, industry pushes back at Trump's 'Buy American' order Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals